Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide and Saxagliptin on Immune Cells in Type 1 Diabetes
NCT01782261Phase 2Completed
- Sponsor
- Medical University of Graz
- Start
- Feb 2012
- Primary completion
- Feb 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of liraglutide in type 1 diabetes mellitus (T1D), sponsored by Medical University of Graz. Started Feb 2012; status: completed.
02
Drugs
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01782261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01782261.